Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Fecal Microbiota Transplantation for Patients With Steroid-Resistant or Relapsed Immune Thrombocytopenia: A Randomized, Double-blind, Placebo-Controlled Phase 2 Trial

NCT07733037 is registered in ClinicalTrials.gov with Peking University People's Hospital as lead sponsor.

NCT NCT07733037
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07733037 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Fecal Microbiota Transplantation for Patients With Steroid-Resistant or Relapsed Immune Thrombocytopenia: A Randomized, Double-blind, Placebo-Controlled Phase 2 Trial
Lead sponsor
Peking University People's Hospital
Phase
Phase 2
Overall status
Active, not recruiting
Start date
January 10, 2026
Completion date
September 30, 2028
Enrollment
42 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

immune thrombocytopenia (itp)